Tc. Beasley et al., INDOMETHACIN ATTENUATES EARLY INCREASES IN INDUCIBLE HEAT-SHOCK-PROTEIN-70 AFTER CEREBRAL ISCHEMIA REPERFUSION IN PIGLETS/, Developmental brain research, 105(1), 1998, pp. 125-135
Indomethacin-sensitive mechanisms involved in inducible heat shock pro
tein 70 (iHSP 70) synthesis were investigated at 6 h after global cere
bral ischemia in parietal cortex and hippocampus. In anesthetized pigl
ets, increased intracranial pressure was used to produce 5 or 10 min o
f cerebral ischemia. Brain regions were sampled for immunoblot analysi
s, immunohistochemistry and morphology. Immunoblots revealed different
ial expression of iHSP 70 in untreated brains. Cerebellum contained su
bstantial amounts of iHSP 70 while lower levels were present in pariet
al cortex and hippocampus. Detectable increases in iHSP 70 were observ
ed at 2 h after ischemia in parietal cortex and hippocampus. Using imm
unoblot data, calculation of percent change from control at 6 h after
ischemia revealed significant (p < 0.05) increases in iHSP 70 of 111 /- 39% ((x) over bar +/- sem) (n = 6) in parietal cortex and 195 +/- 6
9% (n = 8) in hippocampus. Increased iHSP 70 immunoreactivity occurred
primarily in the granular/subgranular area of the dentate gyrus 6 h a
fter ischemia. Histological staining revealed little cellular injury a
t 6 h after ischemia in the granular/subgranular region injury whereas
the CA3 region, which lacked iHSP 70 staining, displayed modest cellu
lar injury. Cellular injury was also observed in cortical layers II/II
I and VI. At 6 h after ischemia, indomethacin pretreatment (5 mg/kg, i
.v.) attenuated the iHSP 70 increases in parietal cortex and hippocamp
us (7 +/- 30% and 89 +/- 30%, respectively n = 5; p < 0.05 compared to
ischemia). Also, the increase in iHSP 70 immunoreactivity and appeara
nce of cellular injury were not detected with indomethacin pretreatmen
t. Thus, prior administration of indomethacin is associated with atten
uation of ischemia-induced increases in iHSP 70 and cellular injury. (
C) 1998 Elsevier Science B.V.